Connecting to SEC EDGAR… PricingSign in
← All filings
CG Oncology, Inc.CGON · Nov 6, 8:30 AM ET

CG Oncology reports Q3 2026 net loss of $56.9 million

CG Oncology reported a third-quarter 2026 net loss of $56.9 million, or $(0.64) per share, and cash of $984.5 million expected to fund operations through 2029.

AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.